Neonatal blockade of NR2A-containing but not NR2B-containing NMDA receptor induces spatial working memory deficits in adult rats

Neurosci Res. 2022 Mar:176:57-65. doi: 10.1016/j.neures.2021.10.005. Epub 2021 Oct 14.

Abstract

The immature brain is highly sensitive to disturbances in the functioning of N-methyl-d-aspartate (NMDA) receptor in rodents, and blockade of the receptor during postnatal brain development period causes schizophrenia-like behavior in adulthood. During the postnatal period, NR2A- and NR2B-containing NMDA receptors are highly expressed, and these two subunits show different expression patterns in the brain. However, the functions of these two NMDA receptors are unknown. In this study, we treated rats with an NR2A-preferring NMDA receptor antagonist (PEAQX, 10 mg/kg), an NR2B-selective NMDA receptor antagonist (ifenprodil, 7.5 mg/kg), or a nonselective blocker of the NMDA receptor (MK-801, 0.4 mg/kg) during the neonatal period. Rats neonatally treated with MK-801 or PEAQX showed spatial working memory deficits in the Y-maze test. PEAQX-treated rats also showed greater reactivity to acoustic stimuli and hypersensitivity to acute MK-801 challenge. However, ifenprodil treatment did not cause any detectable behavioral changes. These results suggest that the NR2A-containing NMDA receptor is indispensable for proper brain development in rats, and functional disturbances in this subunit impair hippocampus-dependent spatial working memory in adulthood.

Keywords: Chronic postnatal treatment; N-methyl-d-aspartate receptor; NR2 subunit; Rat; Schizophrenia; Spatial working memory.

MeSH terms

  • Animals
  • Excitatory Amino Acid Antagonists* / metabolism
  • Excitatory Amino Acid Antagonists* / pharmacology
  • Hippocampus / metabolism
  • Memory Disorders / chemically induced
  • Memory, Short-Term
  • Rats
  • Receptors, N-Methyl-D-Aspartate / metabolism*

Substances

  • Excitatory Amino Acid Antagonists
  • NR2B NMDA receptor
  • Receptors, N-Methyl-D-Aspartate